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Abstract 
Long chain polyunsaturated fatty acids (LC-PUFA) are essential to humans and 
needs to be consumed through the diet instead of production in the body. LC-
PUFAs are in this report be categorized into omega-3 and omega-6 fatty acids. The 
aim of this study was to focus on LC-PUFAs that can be produced by species of 
microalgae of commercial interests.  
There are estimated to exist 200 000 up to millions species of microalgae and the 
species are as diverse in cultivation strategies as in products. Strains of Arthrospira 
produce γ-linoleic acid (GLA). Crypthecodinium species and Schizochytrium spe-
cies produce docosahexaenoic acid (DHA).  Nannochlorpsis species, Nitzschia 
species and Phaeodactylum species can be cultivated for the production of eicosa-
pentaenoic acid (EPA). Porphyridium species are potential for the production of 
arachidonic acid (AA).  
The LC-PUFAs are important due to a wide range of health beneficial services. 
EPA and AA are the most important producers to eicosanoids among the fatty ac-
ids. Eicosanoids are important in the process of cell-signalling and also respond to 
inflammations. Categories of eicosanoids are prostaglandins, leukotrienes and 
thromboxane’s that are included in blood pressure reductions, pro-inflammatory 
effects, aggregation of thrombocytes and artery contractions et cetera.  
Major depression disease and Alzheimer disease are suggested to benefit from 
supplements of LC-PUFA. EPA and DHA are part of membranes in the brain, and 
can improve cognitive functions, hence, have preventative effects to Alzheimer and 
major depression disease. Cardiovascular disease may also be prevented if suffi-
cient omega-3 fatty acids are consumed. Eicosanoids derived from LC-PUFA may 
also affect the inflammatory response in the body. Eicosanoids derived from AA 
have a more severe inflammatory response, while eicosanoids derived from EPA 
and DHA can have anti-inflammatory response.     
Keywords: Micro algae, LC-PUFA, Eicosanoids 
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Sammanfattning 
Långkedjiga fleromättade fettsyror (LC-PUFA) är essentiella för människan vilket 
innebär att de måste förtäras via dieten eftersom en produktion i kroppen inte är 
möjlig. LC-PUFA kan i den här rapporten kategoriseras in i 2 huvudgrupper; 
omega-3 och omega-6. Syftet med denna litteraturstudie var att fokusera på LC-
PUFA som kan produceras av olika arter av kommersiellt intressanta mikroalger.  
Det beräknas att existera 200 000 till miljontals arter av mikroalger i världen. Ar-
terna är lika mångfaldiga i sin artskildhet som i odlingsstrategi och i sammansätt-
ning. Stammar av Arthrospira producerar γ-linolensyra (GLA). Arter av 
Crypthecodinium och Schizochytrium är potentiella för odling av dokosahexansyra 
(DHA). Arter av Nannochloropsis, Nitzschia och Phaeodactylum är potentiella för 
odling av produktion av Eikosapentaensyra (EPA). Arter av Porphyridium kan 
potentiellt odlas för produktion av arakidonsyra (AA).  
LC-PUFA konsumtion är viktig på grund av sina utbredda hälsoförtjänster. EPA 
och AA är de viktigaste producenterna bland fettsyrorna till en rad olika eikosa-
noider. Eikosanoider är viktiga i processer så som cellsignalering och ger gensvar 
på inflammation. Det finns olika kategorier av eikosanoider så som prostaglandiner, 
leukotriener och tromboxaner. Dessa ingår i funktioner som blodtryckssänkning, 
trombocytaggregering, kärlsammandragningar et cetera.  
LC-PUFA kan påverka, enligt studier, hälsan hos sjuka individer. Depressions-
sjukdomar och Alzheimers har studier föreslagit att motverkas på grund av intag av 
LC-PUFA. EPA och DHA utgör delar av fosfolipider och membran i hjärnan samt 
kan förbättra kognitiva funktioner. Hjärt- och kärlsjukdomar kan också förebyggas 
om omega-3 fettsyror konsumeras, enligt studier. Eikosanoider ursprungligen från 
LC-PUFA kan även påverka den infammatoriska responsen i kroppen. Eikosanoider 
från AA har en rikligare inflammatorisk respons medan eikosanoider från EPA och 
DHA kan ha antiinflammatorisk respons.  
Nyckelord: Mikroalger, LC-PUFA, Eikosanoider 
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 AA Arachidonic acid 
ALA α-Linolenic acid 
COX Cyclooxygenase 
D-GLA Dihomo γ-linoleic acid 
DHA Docosahexaenoic acid 
EPA Eicosapentaenoic acid 
GLA γ-Linolenic acid 
LA Linoleic acid 
LC-PUFA Long chain polyunsaturated fatty acid 
PUFA Polyunsaturated fatty acid 
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1 Introduction 
Algae are organisms that include a wide range of species that perform approxi-
mately 50% of the photosynthesis on the globe (John, 1994). Algae may be 
macroalgae or microalgae which in both categories includes diversities. Microal-
gae, also called microphytes, are in focus in this report. In contrast to macroalgae 
are microalgae smaller (Olaizola, 2003). 
The concept of microalgae is wide, and contain all organisms that are small 
enough (a few μm), unicellular and can mostly live in environments with water. 
The organism may also be photosynthetic and can be eukaryotic or prokaryotic. 
This gives opportunities to a wide range of commercial applications such as hu-
man nutrition, cosmetics and aquaculture and all are not yet explored (Olaizola, 
2003).  
The number of species of microalgae that exist are unknown, though estimated 
to between 200 000 up to millions, while higher plants are estimated to be about 
250 000 species (Pulz & Gross, 2004). 
Diatoms are a category of microalgae of great importance that fixate about 20 % 
of the carbon on the planet (Kroth et al., 2008). Blue-green microalgae or cyano-
bacteria are a category which microalgae show many similarities with, though 
cyanobacteria are bacteria not algae (SMHI, 2010) and have been categorized as 
plants due to the photosynthetic properties, but are now called bacteria due to that 
no defined nucleus exist (Ziboh, 2001).  
Microalgae are at the lowest level in the food chain and a source to long chain 
fatty acids. This give rise to a diversity of wild life in the oceans (Posten & Walter, 
2013). All species of microalgae are not suitable for human consumption. Some 
species have multiple ecosystem favours while some species constitute a risk 
through algae blooming. Thereby, the algae may toxify the surroundings for fish 
and wildlife. Humans that consume toxified shellfish or fish may be poisoned 
(SMHI, 2011).  
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A few species of microalgae have been used as food supplement and as enrich-
ment in feed for centuries. Accustomed examples are Nostoc species in Asia and 
Spirulina (Arthrospira species) in Mexico and Africa (Olaizola, 2003).  
In comparison to how many species of algae that exists, only a few species are 
used since a production needs to be in a large scale, the metabolite of interest 
needs to be found and purified and the process needs to be financially sustainable 
(Olaizola, 2003).   
Arthrospira species, Chlorella species, Dunaliella species, and Aphanizomenon 
species are the four strains that are dominating the commercial industry of micro-
algae as human nutrition. The microalgae act as supplements and natural food 
colorants. Since there are such a wide range of species among microalgae, their 
biofunction and products are equally different. Due to studies Arthrospira species 
produce primarily long chain polyunsaturated fatty acids (LC-PUFA), Dunaliella 
species produce primarily β-carotene, Chlorella species produce primarily chloro-
phyll and Aphanizomenon species promote a good health in general (Spolaore et 
al., 2006).  
According to the variance in biodiversity, bioavailability and products from the 
species of microalgae, their applications are also different. Microalgae are used for 
aquaculture, biofuels, cosmetics, human nutrition, supplements et cetera (Olaizola, 
2003).  
Apart from the four major genus, other important microalgae used for commer-
cial applications are Chaetoceros species that are used for aquaculture and indirect 
consumption. Crypthecodium species and Schizochytrium species are used for 
docosahexaenoic acid-oils (DHA-oils) and Nannochloropsis species are used for 
aquaculture feed (Spolaore et al., 2006). 
Since the 1930’s it has been known that fat is necessary for a good health. Lino-
leic acid (LA, 18:3, n-6) and α-linolenic acid (ALA, 18:3, n-3) were supplemented 
to e.g. cure people diseased with different dermatological problems et cetera 
(Abrahamsson et al., 2013).  
The human body cannot synthetize fatty acids (FA) with double bounds on car-
bon 3 and 6. In different studies, different names rise to longer more unsaturated 
fatty acids such as; long chained polyunsaturated fatty acids (LC-PUFA), essential 
fatty acids (EFA) and polyunsaturated fatty acids (PUFA) (Wiktorowska-
Owczarek et al., 2015).  
LC-PUFAs are essential since the body cannot synthetize them. Two important 
categories of LC-PUFA are omega-3 and omega-6 FA. Omega-3 FA can be con-
sumed in the diet in the form of ALA and can then be transform to longer omega-3 
fatty acids such as docosahexaenoic acid (DHA) and/or eicosapentaenoic acid 
(EPA) in the body. Omega-6 FA can be consumed in the diet in the form of LA 
that can be transformed into the omega-6 fatty acids γ-linolenic acid (GLA) and 
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arachidonic acid (AA). The importance of these LC-PUFAs are their beneficial 
health effects (Livsmedelsverket, 2015b).  
Algae are a source to LC-PUFAs, either through purification of the algae into 
oils, such as DHA-oil, through enrichment of food with dried biomass or through 
use in aquaculture (Spolaore et al., 2006). Potential ways to use algae for LC-
PUFA production are also the use of algae genes, inserted in other crops (Kris-
Etherton & Hill, 2008). 
The aim of this literature analysis was to describe 7 genuses of microalgae that 
are used or potentially can be used in the market of human nutrition for their pro-
duction of LC-PUFA (Harwood & Guschina, 2009). The aim was to answer ques-
tions concerning if the conditions of cultivation of microalgae can affect the nutri-
tional value of LC-PUFA and if microalgae is a possible source in comparison 
with other sources. The functions that the LC-PUFA provide for the human body 
will also be elucidated.  
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2 Method 
Databases such as Web of Science, Scopus, Primo, PubMed and Google Scholar 
were used in the literature analysis. In first hand, scientific journals and review 
articles were studied which referred to more profound scientific publications. The 
scientific publications were chosen by reading the abstract and then those of inter-
est were read more thoroughly. Many sources were dated and therefore as updated 
sources as possible were used primarily, though some dated books were used for 
background facts. Books were searched through the database Primo and were 
viewed and studied online.  
The databases from National Food Agency of Sweden (Livsmedelsverket) were 
used and also the S wedish Meteorology Authority’s website (SMHI). 
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1 Long chained polyunsaturated fatty acids 
In this report the focus is on long chain polyunsaturated fatty acids (LC-PUFA) 
as a product of 7 genuses of microalgae that are cultivated, or has potential to be 
cultivated for this purpose (Harwood & Guschina, 2009). Arachidonic acid (AA, 
20:4 n-6, 9, 12), γ-linolenic acid (GLA, 18:3 n-6, 9, 12), eicosapentaenoic acid 
(EPA, 20:5 n-3 6, 9, 12, 15) and docosahexaenoic acid (DHA, 22:6 n-3 6, 9, 12, 
15,18) are LC-PUFAs that could be connected as a product of the different algae 
species selected (Spolaore et al., 2006). The chemical structure of the essential 
LC-PUFAs can be seen in Table 1 (Appendix).  
The omega 3 and omega 6 fatty acids are essential for humans, since the human 
body cannot create double bounds on carbon 3 and 6 in the fatty acid chains 
(Wiktorowska-Owczarek et al., 2015). This is due to lack of the enzymes Δ12- and 
Δ15-desaturase which inserts the double bounds on the n-3 and n-6 positions. 
Therefore, these fatty acids need to be consumed through the diet (Abrahamsson et 
al., 2013). 
Linoleic acid (LA, cis-9,12-octadecenoic acid) is the original omega-6 fatty acid 
that can be consumed in different food such as; maize-oil, sunflower-oil, rapeseed-
oil, sesame-oil. AA and GLA are also omega-6 fatty acids, deriving from LA, that 
can be developed with help from desaturases and elongases (Livsmedelsverket, 
2015b). Desaturases are enzymes that are necessary to form double bounds and 
different elongases are needed to create longer fatty acid chains (Wiktorowska-
Owczarek et al., 2015).   
α-Linolenic acid (ALA, cis-9,12-octadecatrienoic acid) is the original omega-3 
fatty acid that can be consumed in different food such as walnuts, rapeseed-oil, 
fatty fish and algae. DHA and EPA can be developed from ALA, hence includes 
to be omega-3 fatty acids. There are also other omega-6 and omega-3 fatty acids 
whilst AA is the most occurring in the omega-6 family and DHA and EPA are the 
most occurring in the omega-3 family (Livsmedelsverket, 2015b). The metabolism 
of the LC-PUFAs in the human body can be seen in Table 2 (Appendix).  
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Challenges concerning dietary intake of omega-3 and omega-6 fatty acids are 
that they compete over the same enzymes in the elongation and desaturation pro-
cess (Gebauer et al., 2006). Therefore, LC omega-6 FA is more easily produced in 
the body, since its more abundant in the diet (Gebauer et al., 2006). Though, ome-
ga-3 fatty acids have higher affinity to the enzymes (Abrahamsson et al., 2013). 
Omega-9 fatty acids are also included in this competition (Kinsella et al., 1990). 
1.1 Arachidonic acid 
AA has an important role to play in the human body to create cell membranes to 
integrate the cells and also to produce prostaglandins. The concentration of AA in 
the body tissue is correlated to the dietary intake of LA up to 3 E%. This is the 
point when the phospholipid membranes in the body are saturated with AA.  
There are different ways AA can affect the human body. Lipase enzymes are 
necessary to decompose AA from the phospholipid membranes. To create the 
prostaglandins D, E and F, the cyclooxygenase (COX) enzymes are necessary. In 
the cardiovascular tissue an instable prostaglandin I2 (PGI2) can form by COX and 
in the thrombocytes, thromboxane A2 (TXA2) can form. Another pathway for AA 
is with lipoxygenase enzymes that converts AA to hydroxyl fatty acids, leukotri-
enes and lipoxins (Abrahamsson et al., 2013). 
AA is the most common occurring long chain fatty acid and owns the competi-
tion of lineolate enzymes over EPA and DHA. It is important for humans to con-
sume both omega-6 and omega-3 fatty acids since it is necessary for a normal 
health (Livsmedelsverket, 2015b). Studies show that an elevation of plasma level 
of AA is not often desirable. The accumulation of thromboxane’s and platelet ag-
gregating peroxidases can have pro-inflammatory effects (Barham et al., 2000).  
 
1.2 γ-Linolenic acid 
GLA is an omega-6 fatty acid that is the first product that is produced in the 
body from the dietary intake of LA (Livsmedelsverket, 2015b), commonly from 
vegetable oils. GLA is necessary for the omega-6 metabolism and is created in the 
first desaturation step with Δ6-desaturase. GLA is then quickly transformed into 
dihomo-γ-linolenic acid (D-GLA) by a polyunsaturated fatty acid-elongase. D-
GLA can be transformed further into AA by Δ5-desaturase. The desaturase en-
zymes are membrane bound and needs aerobic conditions (Ziboh, 2001). 
In the body GLA creates D-GLA that together with AA and EPA is the primary 
sources to eicosanoids in the body (Sergeant et al., 2016). 
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A wide range of diseases, such as i.e. cancer and diabetes, have negative impact on 
the development from LA into GLA. Inhibited initial pathway to omega-6 fatty 
acids can be solved through supplements of GLA. By passing the first Δ6-
desaturaton step, LC-PUFA may be created and instead have beneficial health 
effects on the diseased. This has been applied in many medicinal purposes (Ziboh, 
2001). Even though, supplements of GLA are in some aspects discussed due to 
that the GLA that is not transformed to D-GLA, can accumulate the plasma levels 
of AA. High plasma levels of AA can in turn have pro-inflammatory properties 
(Barham et al., 2000). Besides, D-GLA do not create any prostaglandin or throm-
boxane of importance (Abrahamsson et al., 2013). 
1.3 Eicosapentaenoic acid  
EPA is an omega-3 fatty acid that can be transformed in the body from ALA in 
the diet. ALA is often rich in fish, shellfish, rapeseed et cetera (Livsmedelsverket, 
2015b).  
EPA has important health influencing effects on humans. EPA is an important 
source to eicosanoids in the body together with AA and D-GLA and can synthetize 
the prostaglandin PGI3, that is similar to PGI2, that has cardio vessel dilating ef-
fects (Abrahamsson et al., 2013).  
Since omega-6 FA is more abundant in the diet of the western society than 
omega-3 fatty acids, approximately in 10:1 ratio, this may lead to that AA is more 
abundant in membranes and tissues of the human body (Parker et al., 2006). Ome-
ga-3 fatty acids have a higher affinity to the elongating enzymes in the body and 
can inhibit the synthesis of AA, and be more abundant in the body (Abrahamsson 
et al., 2013).  
EPA produce the prostaglandin PGI3 that has similar effects as PGI2 from AA, 
while thromboxane from EPA has no crucial effect (Abrahamsson et al., 2013). 
1.4 Docosahexaenoic acid  
DHA is an omega-3 fatty acid that can be transformed in a minor amount in the 
body from ALA, which is widespread in the diet. Fish and algae are good sources 
to DHA and can be consumed directly (Livsmedelsverket, 2015b). Studies claim 
that the transformation from dietary ALA is insufficient and only occurs into DHA 
and EPA in 10-15% (Parker et al., 2006). A series of elongation and desaturation 
steps needs to occur to produce DHA in the human body from ALA (Sergeant et 
al., 2016).   
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2 Health effects from LC-PUFA 
LC-PUFA create health effects in the human body that may prevent, slow down 
or improve health (Abrahamsson et al., 2013). Different studies point out that Alz-
heimer disease, cardiovascular disease, inflammation and major depression disease 
may have beneficial health aspects from the dietary intake from LC-PUFA (Song 
et al., 2016; Mori & Beilin, 2004; Kris-Etherton et al., 2003).  
Beneficial health effects are due to eicosanoids, derived from fatty acids with 20 
carbon atoms, that can control cell signalling and respond to inflammations 
(Abrahamsson et al., 2013).  
Studies have shown that beneficial health effects such as anti-inflammatory re-
sponse are due to D-GLA (Sergeant et al., 2016). DHA is crucial for a normal 
brain activity, the nervous system and the cardiovascular system. This is especially 
during development for a growing and maturing child (Abrahamsson et al., 2013). 
2.1 Alzheimer disease 
The human brain contains high levels of PUFA. Due to this facts, studies have 
been performed concerning brain health and its correlation to PUFAs, such as EPA 
and DHA (Logan, 2003). 
 Alzheimer disease is a brain disease which has no cure and only have a few op-
tions for treatment (Swanson et al., 2012). LC-PUFA may be preventative factors 
since the brain benefit from their functions. EPA and DHA have important func-
tions in membranes, inflect the neuroimmune and apoptotic pathways and also 
compete over enzymes with omega-6 fatty acids that may have pro-inflammatory 
effects (Song et al., 2016).  
Studies have shown that neurological functions have improved in correlation 
with a high intake of DHA in proportion to EPA and that patients with a mild form 
of Alzheimer might benefit from supplements of DHA and EPA through e.g. im-
proved cognitive functions (Swanson et al., 2012).   
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2.2 Cardiovascular disease 
Studies have shown that people with cardiovascular disease (CVD) can have bene-
ficial health effects from supplements or food rich in omega-3 fatty acids, such as 
fish. 
   Intervention studies imply that high blood pressure can be partially reduced, and 
that high fat compared to low fat and enhanced LA have blood pressure reducing 
effect. Blood coagulation, aggregation of thrombocytes and extended bleeding 
time are functions dependent on DHA and EPA (Abrahamsson et al., 2013).  
Three epidemiological prospective studies showed that grown men that had an 
intake of fish more than once a week had decreased risk for coronary heart diseas-
es (Kris-Etherton et al., 2003). The aspect to how women respond to the dietary 
intake of fish has been concluded to lower risk for coronary heart disease, accord-
ing to “The Nurses’ health study”, (Hu et al., 2002) performed over 16 years. 
Though, a number of prospective cohort studies on women showed that athero-
sclerosis could benefit from the dietary intake of fish, which was contradictory to 
the studies done in men (Hu et al., 2002). 
2.3 Inflammation 
Eicosanoids from omega-6 fatty acids are suggested to create inflammation if 
high dietary intake occur. Eicosanoids derived from AA are proposed as even 
more severe in the inflammatory response which can be modulated by EPA and 
DHA derived eicosanoids (Abrahamsson et al., 2013).  
In the aspect of anti-inflammatory response, the EPA and DHA omega-3 fatty 
acids from marine-oil are effective (Mori & Beilin, 2004).   
Cytokine production and development of lymphocytes and reactive oxygen rad-
icals are all pro-inflammatory markers, that can be inhibited by eicosanoids de-
rived from EPA and DHA. Therefore, immunological diseases, psoriasis, hyper-
sensitivity, lymphocytes, rheumatism and intestinal diseases have been suggested 
to be prevented from EPA and DHA (Abrahamsson et al., 2013).   
The anti-inflammatory effects deriving from EPA and DHA are shown in trials, 
preventing atherosclerosis, sudden death, myocardial infarction et cetera (Mori & 
Beilin, 2004). Studies show that high dietary intake of trans fatty acids and satu-
rated fatty acids in comparison to alpha linolenic acid give rise to pro-
inflammatory markers. Exceeding 10 E% of PUFA can give rise to peroxides in 
the body which can be reduced by vitamin E in the diet (Abrahamsson et al., 
2013).  
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2.4 Major depression disease  
Major depression disease (MDD) is a common illness of the brain. Approxi-
mately 10% of the population in the world is affected and gets depressive, down-
hearted, unmotivated, indifferent and apathetic (Song et al., 2016).  
Studies have shown that the lipid levels in the bloodstream are less dense in 
people with MDD or similar diseases, and more abundant in healthy people. Re-
search emphasize the importance of LC-PUFA to the central nervous systems 
which can be preventative to various of neuropsychiatric disorders (Logan, 2003). 
Other studies show connection between MDD and stress, which give rise to 
dysfunctional hormone levels in the brain and results in low amount of neuro-
transmitters such as dopamine, serotonin and noradrenaline (Song et al., 2016).  
Other studies show that post-traumatic stress from pregnancies can have beneficial 
effects, if treated with LC-PUFA (De Vriese et al., 2003). 
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3 Microalgae species and LC-PUFA 
    The microalgae species that are in focus in this report are Arthrospira species, 
Cryptecodium species, Nannochloropsis species, Nitzchia species, Phaeodatylum 
species, Porphyridium species and Schizochytrium species. These species were 
chosen in this report due to their production of LC-PUFA; AA, GLA, EPA and 
DHA (Harwood & Guschina, 2009). The microalgae are used in products in the 
market or are potential industrial products. (Posten & Walter, 2013). 
Strategies to increase LC-PUFA content in microalgae are well studied. Exam-
ples of strategies are the possibility of optimization of temperature. The light in-
tensity can be altered, as well as nutrients, the concentration of carbon dioxide, the 
pH and the salt concentration. There are also more factors that can be included to 
demonstrate that there are many different ways to alter the composition of the 
microalgae (Cavonius, 2016). The fatty acid content of the microalgae genuses 
seen in Table 1. in Appendix is modified by a study and describes the content of 
DHA and EPA in percent of the dried biomass and the yield DHA and EPA in 
milligram per litre of the total batch cultivation.  
Studies results in different values of the total lipid content of microalgae genus-
es. In a study the lipid composition of different microalgae genuses was deter-
mined by thin-layer chromatography-flame ionization detection. The lipid classes 
the microalgae species contained were hydrocarbons, triacylglycerols, free fatty 
acids, sterols and polar lipids (Volkman et al., 1989). 
 Microalgae yield more oil than conventional crops due to that microalgae use 
the vegetable oil as storage product, and contain about 50-60% lipids per dry 
weight of the total biomass  (Griffiths & Harrison, 2009). Approximated value of 
LC-PUFA of the total lipids in percent is given in Table 2. in Appendix. 
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3.1 Arthrospira species 
Arthrospira species are blue-green microalgae, which in the market for human 
consumption are also called Spirulina. Spirulina is categorized to be a microalgae, 
but are really spiral shaped dietary consumable cyanobacteria (Vonshak, 1997).   
Arthrospira species have long been studied for its fatty acid composition 
(Muhling et al., 2005). Food supplement oils from Arthrospira species can provide 
rich amounts of GLA. The total lipid content is in general 6-7% of the dried bio-
mass of Spirulina maxima (Spolaore et al., 2006).  
Due to one study on S. plantensis the content of PUFA was 18.6%, monoun-
saturated fatty acids (MUFA) 1.9% and saturated fatty acids (SFA) 70.3% of the 
total lipid content. GLA was the major fatty acid of the PUFA (18.5%) followed 
by LA (13.8%). Also existing were palmitic acid, palmitoleic acid and oleic acid 
(Yasar & Sevket, 2006).  
Arthrospira species are suitable for cultivating for human consumption since 
they are rather large in comparison with most microalgae, rich in protein and easi-
ly can be digested. The production of GLA can be altered by growth conditions 
such as light intensity, growth phase and temperature. Studies show that the 
growth condition in 30-35 °C for most strains of Arthrospira is richest in GLA. 
High light intensity and temperature reduces fatty acid content but not composition 
(Cohen et al., 1987). Arthrospira species have been suggested to have an opti-
mized growth under light and dark cycles in laboratory environment or outdoors 
(Tanticharoen et al., 1994). 
 
3.2 Crypthecodinium species 
Crypthecodinium cohnii is a heterotrophic microalga that is grown for food and 
pharmaceutical interests for the production of DHA-oil. Studies has been made on 
growth conditions to optimize the production of DHA-oil. One study used batch 
cultivation with sea salt, yeast extract and glucose and compared with another 
batch with acetic acid as carbon source. The batch with acetic acid showed high 
biomass, DHA and lipid concentrations (De Swaaf et al., 2003). 
 Crypthecodinium species are studied to produce DHA (Spolaore et al., 2006). 
A recent study determined the DHA and EPA proportion of the dried biomass of 
Crypthecodinium cohnii. The results showed that it contained 0.8-1.3% DHA and 
0% EPA of the dried biomass and measured in milligram fatty acids per litre of 
batch culture, DHA reached 15-20 mg/L and EPA 0 mg/L (Cavonius, 2016). 
Hence, that Crypthecodinium cohnii almost exclusively produces DHA makes it a 
good microorganism for purification process of lipids (Mendes et al., 2009).  
17 
 
3.3 Nannochloropsis species 
Nannochlorpsis species are green microalgae that are cultivated for their chlo-
rophyll, carbohydrate, protein and fatty acid content and some Nannochloropsis 
species also produce LC-PUFA (Volkman et al., 1989). Some species of Nanno-
chlorpsis, have been shown to produce EPA (Spolaore et al., 2006). In a study, 
Nannochlorpsis species grown under enriched CO2 phototrophic culture condi-
tions gave a higher yield of EPA compared to acetate enriched mix trophic condi-
tions (Hu & Gao, 2003). 
Nannochloropsis occulta is composed of 17.8-39.9% EPA of the total fatty acid 
content (Renaud et al., 1991). A recent study determined the DHA and EPA pro-
portion of the dried biomass of Nannochlorpsis species. The results showed that it 
contained 0-0.7% DHA and 0-8.2% EPA and contained 0-2.6 mg/L DHA and 0-14 
mg/L EPA in the total batch culture (Cavonius, 2016).  
3.4 Nitzschia species  
Nitzschia laevis is a diatom (Chen et al., 2007), which means that the microalga 
contain silicon in the cell wall (SMHI, 2011). 
Nitzschia species have been confirmed to produce EPA (Spolaore et al., 2006). 
In a study Nitzschia laevis showed that the EPA production was most sufficient in 
a mix trophic growth culture compared to using single trophic conditions (Wen & 
Chen, 2000).  Nitzschia laevis is a potential for production of EPA and the distri-
bution of EPA has been shown to be spread among the classes of lipids. In one 
study regarding Nitzschia laevis, the total lipid content constituted 78.6% neutral 
lipids. Out of these neutral lipids, 87.9% was triacylglycerols and out of the tri-
acylglycerols, 75.9% was EPA (Chen et al., 2007). 
A recent study determined the DHA and EPA proportion of the dried biomass 
of Nitzschia species. The results showed that it contained no detected DHA and 
1.1-1.5% EPA and the total batch culture contained no detected  DHA/EPA in 
mg/L (Cavonius, 2016). 
3.5 Phaeodactylum species  
Phaeodactylum tricornitum are diatoms that are potentially used for the produc-
tion of EPA-oil for omega-3supplement. Phaeodactylum species have been con-
firmed to produce EPA (Spolaore et al., 2006). A study showed that the cultivation 
of Phaeodactylum tricornitum have higher production of EPA and PUFA at slight-
ly lower temperatures than at higher temperatures (Jiang & Gao, 2004).  
In another study of the fatty acid composition, it was found that the EPA con-
tent was high in the strains studied. The highest amount of EPA was 25.65% of the 
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total lipids (Wu et al., 2016). A recent study determined the DHA and EPA pro-
portion of the dried biomass of Phaedactylum tricornutum. The results were 0-
0.4% DHA and 0.2-5.5% EPA and the total batch culture contained 0-11 mg/L 
DHA and 1.3-130 mg/L EPA (Cavonius, 2016). 
3.6 Porphyridium species  
Porphyridium species are red marine microalgae that produce the LC-PUFAs 
AA and EPA. AA is of special interest since it is unusual to be produced (Cohen et 
al., 1988). A study showed that slow growth conditions and nitrogen starvation on 
Porphyridium cruentum resulted in the highest values 2.9% AA in ash free dry 
weight and 2.4% EPA of total lipids in ash free dry weight (Cohen, 1990).  Micro-
algae are produced for DHA-oils and EPA-oils as food supplements (Spolaore et 
al., 2006). The Porphyridium species produce AA and have potential to be directly 
consumed (Spolaore et al., 2006). 
To be able to yield the production of AA by Porphyridium species it is suggest-
ed that the light intensity should be 8000 lux and the temperature 32 ̊C in liquid 
cultures of 12 x 109 cells/L (Ahern et al., 1983). A recent study determined the 
DHA and EPA proportion of the dried biomass of Porphyridium species. The re-
sults were 0% DHA and <0.1-3.8% EPA and the total batch culture contained 0 
mg/L DHA and <1-69 mg/L EPA (Cavonius, 2016). 
3.7 Schizochytrium species  
Schizochytrium species are thraustochytrids, which means algae-like fungi 
(Ziboh, 2001).  Schizochytrium species are marine microheterotrophic organisms, 
which has been detected to produce high biomass containing LC-PUFA. Though, 
these LC-PUFA profiles are rather complex and that yields production costs. 
Thraustochytrids with simpler LC-PUFA profiles are preferable in a production 
point of view (Lewis et al., 1999).  
Schizochytrium species produce DHA (Spolaore et al., 2006). The Schizochytri-
um species strain 31 can improve production of DHA when the cultures are incu-
bated during 4 days with initial of pH 7.0, with 0.4% (w/v) yeast extract and with 
20 g/L glucose (Wu et al., 2005). 
Schizochytrium mangrovei isolated from decaying mangrove forest in Hong 
Kong was studied for fatty acid content and DHA was found to be the most abun-
dant fatty acid. The percentage DHA was 32.29-39.14% of the total fatty acid 
content (Jiang et al., 2004). A recent study determined the DHA and EPA propor-
tion out of the dried biomass of Schizochytrium aggregatum. The results were 0-
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0.3% DHA and 1.0-1.2% EPA and the total batch culture contained 0-<1 mg/L 
DHA and 6.1-9.3 mg/L EPA  (Cavonius, 2016). 
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4 Discussion  
Many studies have shown that the composition of microalgae can be altered due 
to different culture conditions. Different strains in each species prefer different 
conditions and some strains produce more LC-PUFA than others (Wu et al., 2005; 
Hu & Gao, 2003; Jiang et al., 1999; Renaud et al., 1991).  
Fish oil is used as the main source for supplements of EPA and DHA, and stud-
ies show this to be successful(Parker et al., 2006; Kris-Etherton et al., 2003). 
Fish industries have concerns regarding sustainability though microalgae may 
be an alternative. Microalgae are also superior to crops that accumulate omega-3 
FA, in the aspect of cultivation space, maturation time and higher growth rate 
(Mercer & Armenta, 2011).  
Studies have shown that fish accumulate toxins and pollutants which have given 
an increased interest in microalgae as supplements in replacement (Mimouni et al., 
2015). Pregnant women that are especially sensitive for the safety for their fetus 
are recommended to limit their dietary intake of some fish (Livsmedelsverket, 
2015a).  
A downside to microalgae cultivation is the use of water. The large amount of 
water in the algae culture requires cheap energy methods to dry the biomass 
(Cavonius, 2016).  
The separation methods that are used to release lipids into organic solvents from 
microalgae are not environmentally sustainable. Methods, to be able to use micro-
algae as an environmental alternative to gain LC-PUFA is under research and one 
study shows that it is possible to take advantage of the solvent characteristics and 
use pH shifting to extract soluble material (Cavonius, 2016).  
Some algae might be better than others depending on what kind of LC-PUFA 
that is of interest. Though, the quota of EPA and DHA that is most beneficial is 
not possible to determine. The total amount of dietary intake of EPA and DHA is 
more important for a good health (Livsmedelsverket, 2015b). Microalgae supple-
ment may be a good source to LC-PUFA as long as common food is not neglected 
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(Livsmedelsverket, 2015c). Fish is a good source within reasonable ranges 
(Livsmedelsverket, 2015a). 
Microalgae are a good source to LC-PUFAs if cultivated in financially sustain-
able systems. Microalgae are only discussed superficially due to the existing thou-
sands of species. Microalgae need less cultivations space than plants and fishery 
ponds and produce high biomass. Microalgae yield about 50-60% dry weight li-
pids of the total biomass which is more oil production than conventional crops due 
to that microalgae use the vegetable oil as storage product.  
In comparison with how many species of algae that exists, only a few species 
are used since a production needs to be in large scale and the metabolite of interest 
needs to be found and purified to be financially sustainable. 
LC-PUFA are essential for humans and can in some cases be needed for sup-
plements, especially for target groups. LC-PUFA is needed for the infant’s devel-
opment, pregnant women also need to keep this in mind, hence algal supplement 
may be suitable. Microalgae (wet mass) do not contain pollutants and toxins in 
same range as fish products.  
The correlation between the dietary intake of omega-3 and omega-6 fatty acids 
is more important than the actual amount out of each category, while the optimal 
correlation is not set. 
There is need for more controlled clinical trials with more subjects to be able to 
draw more conclusions considering microalgae. It is crucial to distinguish socio-
demographic variables such as gender, age et cetera in the trials. This is due to the 
fact that LC-PUFA is more important during different stages in the maturation 
phases and also to different individuals.  
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Figure 1. Chemical structures of LC-PUFA, modified from: (Abedi & Sahari, 2014). 
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Tabell 1. Microalgae used for human nutrition and the production of DHA and EPA of 
dried biomass in % and the yield of fatty acids of batch cultivation in mg/L. Modified from 
Cavonius, 2016.  
 
 
Genuses DHA (% of 
dried biomass) 
EPA (% of 
dried biomass) 
DHA (mg/L)  EPA (mg/L )  
Cryptecodinium 
cohnii 
0.8-1.3 0 15-20 0 
Nannochlorpsis 
species 
0-0.7 0-8.2 0-2.6 0-14 
Nitzschia species Not detected 1.1-1.5 Not detected Not detected 
Phaeodactylum 
tricornutum 
0-0.4 0.2-5.5 0-11 1.3-130 
Porphyridium spe-
cies 
0 <0.1-3.8 0 <1-69 
Schizochytrium 
aggregatum 
0-0.3 1.0-1.2 0-<1 6.1-9.3 
 
 
Tabell 2. Microalgae species used for human nutrition. The approximated value LC-PUFA of the 
total lipids and other approximated FA values. DHA= docosahexaenoic acid, EPA= eicosapentaenoic 
acid, MUFA= monounsaturated fatty acids, NL= neutral lipids, SFA= saturated fatty acids, TAG= 
triacylglycerols ((1) Cavonius, 2016; (2) Wu et al, 2016; (3) Chen et al, 2007; (4) Jiang et al, 2004; 
(5) Cohen, 1990; (6) Yasar & Sevket, 2006). 
(Cavonius, 2016; W u et al., 2016;  Chen et a l., 2007; J iang et al. , 2004 ; Cohen, 1990 ; Harrington & Holz, 1968). 
Genuses Approximated value 
LC-PUFA of total 
lipids (%) 
Other approximated 
FA values and lipids 
Arthrospira species  
 
18.6 (7) 1.9% MUFA, 70,3% SFA  
of total lipids (6) 
Crypthecodinium species  30-50 (1) 0.8-1.3% DHA, 0% EPA  
of dried biomass (1) 
Nannochloropsis species  0-8.2 (1) 0-0.7% DHA, 0-8.2% EPA 
of dried biomass (1) 
Nitzschia species 
 
- 75.9% EPA of 87.9% TAG of 
78.6% NL of total lipids (3) 
Phaeodactylum species 
 
25.6 (2) 0-0.4% DHA, 0.2-5.5% EPA 
of dried biomass (1) 
Porphyridium species 0- 2.9 (5) 0% DHA, <0.1-3.8% EPA 
Of dried biomass (1) 
Schizochytrium species 
 
32.2-39.1 (4) 0-0.3% DHA, 1.0-1-2% EPA 
Of dried biomass (1) 
 
  
  
 
28 
 
